According to a report by The Straits Times, “The early-stage clinical trial for a COVID-19 vaccine has started in Singapore, with the first vaccinations expected to be given to volunteers next week. Called Lunar-Cov19, the vaccine is developed by Duke-NUS Medical School and United States pharmaceutical company Arcturus Therapeutics”.
The trail is expected to end by October. Researchers are currently screening the trail volunteers to check whether they are suitable for the trial or not. Trail of the vaccine is being administered by the SingHealth Investigational Medicine Unit.
Associate Professor Jenny Low, deputy clinical and scientific director at the SingHealth unit, on Saturday said that more than 250 people have expressed their interest to participate in the trail.
She said, “As the trial is open to volunteers from 21 to 80 years old, we continue to be on the lookout for more participants, especially those in the older age group”.